PNEUMONIA - BACTERIAL
Clinical trials for PNEUMONIA - BACTERIAL explained in plain language.
Never miss a new study
Get alerted when new PNEUMONIA - BACTERIAL trials appear
Sign up with your email to follow new studies for PNEUMONIA - BACTERIAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New vaccine aims to shield older adults from pneumonia
⭐️ VACCINE ⭐️ CompletedThis study tested a new vaccine called Pn-MAPS30plus to see if it is safe and helps the body fight pneumonia-causing bacteria. It involved 127 healthy adults aged 50 to 64. The vaccine is designed to protect against more types of the bacteria than current vaccines.
Matched conditions: PNEUMONIA - BACTERIAL
Phase: PHASE1 • Sponsor: GlaxoSmithKline • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 13:02 UTC
-
New combo test aims to spot ventilator pneumonia faster
Diagnosis CompletedThis study looked at 173 adults on ventilators to see if combining advanced germ-detection tests with a patient's immune response can improve diagnosis of ventilator-associated pneumonia. Researchers compared several molecular tests and host-response markers to standard clinical …
Matched conditions: PNEUMONIA - BACTERIAL
Sponsor: Duke University • Aim: Diagnosis
Last updated Jun 27, 2026 12:25 UTC
-
AI reads chest X-Rays to spot deadly ICU lung infections
Diagnosis CompletedThis study looked at whether an artificial intelligence (AI) tool can help doctors diagnose ventilator-associated pneumonia (a serious lung infection) in ICU patients. Researchers analyzed chest X-rays from 119 adults on breathing machines, comparing the AI's readings to doctors'…
Matched conditions: PNEUMONIA - BACTERIAL
Sponsor: Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:03 UTC
-
New vaccine AFX3772 aims to shield infants from pneumonia
Prevention CompletedThis study tested a new vaccine called AFX3772 in healthy infants about 2 months old. The goal was to see if it is safe and triggers a strong immune response against pneumococcal bacteria, which can cause pneumonia and other serious infections. Researchers compared AFX3772 with e…
Matched conditions: PNEUMONIA - BACTERIAL
Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: Prevention
Last updated Jun 27, 2026 07:55 UTC
-
Are hidden immune defects causing your recurring infections? new study investigates.
Knowledge-focused CompletedThis study looked for hidden immune system problems in adults who get frequent or severe bacterial infections, like pneumonia or meningitis. Researchers screened 120 adults aged 18-65 to see how many had an undiagnosed primary immunodeficiency. The goal was to find out if these c…
Matched conditions: PNEUMONIA - BACTERIAL
Phase: NA • Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
New alert system aims to cut unnecessary antibiotics in pneumonia patients
Knowledge-focused CompletedThis study tested whether electronic alerts and structured messages from an antibiotic stewardship team could reduce antibiotic use in hospitalized patients with suspected pneumonia. 107 adults were enrolled, and those with test results suggesting viral infection were randomly as…
Matched conditions: PNEUMONIA - BACTERIAL
Phase: NA • Sponsor: Jonathan Baghdadi • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
New rapid test could help ICU doctors pick the right antibiotic faster
Knowledge-focused CompletedThis study tested whether a rapid test called Unyvero could help doctors choose the right antibiotic sooner for patients with pneumonia who are on breathing machines in the ICU. The test looks for bacteria and their resistance genes in just a few hours, compared to standard lab c…
Matched conditions: PNEUMONIA - BACTERIAL
Phase: NA • Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
New tool could spot tough pneumonia early
Knowledge-focused CompletedThis study created and tested a risk score called RESPIRE to predict whether a patient's pneumonia is caused by multidrug-resistant bacteria. Researchers looked at data from 300 adults with community-acquired pneumonia in the emergency department. The goal is to help doctors quic…
Matched conditions: PNEUMONIA - BACTERIAL
Sponsor: Azienda Ospedaliero-Universitaria Careggi • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC